COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS
COULD COVID-19 TRIGGER TYPE 1 DIABETES? PRESENTATION OF COVID-19 CASE PRESENTED WITH DIABETIC KETOACIDOSIS
复制标题
DOI：
10.4183/aeb.2021.532
复制
发表时间：
2021-10-01
影响因子：
1
通讯作者：
Sahin, I.
中科院分区：
文献类型：
--
作者：
Genc, S.;Evren, B.;Sahin, I.
COVID-19是一种病毒性疾病，现已被世界卫生组织认定为大流行病。众所周知，一些病毒感染可能引发自身免疫性疾病。研究发现，COVID-19还可能导致一些自身免疫性疾病的发病，包括1型糖尿病（T1 DM）和自身免疫性甲状腺疾病。在这里，我们的目的是介绍一位年轻的女性COVID-19患者，我们在我们的诊所进行了随访，她出现了糖尿病酮症酸中毒（DKA），并在治疗过程中发展为桥本氏病。为了强调COVID-19可能引发T1 DM的出现，它可能掩盖非特异性DKA症状，如恶心和呕吐，它可能导致DKA诊断延迟，并强调评估伴随COVID-19的其他自身免疫性疾病的重要性，我们发现提出该病例是合适的。
COVID-19 is a viral disease that is recognized now as a pandemic by the World Health Organization. It is known that some viral infections may trigger autoimmune diseases. It has been revealed that COVID-19 may also lead to the pathogenesis of some autoimmune diseases, including Type 1 DM (T1DM) and autoimmune thyroid diseases. Here, we aimed to present a young female patient with COVID-19, who we followed up in our clinic, who presented with diabetic ketoacidosis (DKA), and developed Hashimoto's disease during the treatment process. In order to emphasize that COVID-19 may trigger the emergence of T1DM, that it may mask nonspecific DKA symptoms like nausea and vomiting, that it may cause delay in diagnosis of DKA, and also to emphasize the importance of evaluating other autoimmune diseases accompanying COVID-19, we found it appropriate to present this case.